<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4703">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04596657</url>
  </required_header>
  <id_info>
    <org_study_id>20-455</org_study_id>
    <nct_id>NCT04596657</nct_id>
  </id_info>
  <brief_title>Vitamin D3 Supplementation to Prevent Respiratory Tract Infections</brief_title>
  <official_title>Vitamin D3 Supplementation to Prevent Respiratory Tract Infections in Hospital Workers: a Pragmatic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cooper Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Won Sook Chung Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cooper Health System</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Cooper vitamin D3 study is a randomized study investigating whether daily vitamin D3&#xD;
      supplementation can prevent respiratory tract infections in hospital workers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 27, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory tract infection</measure>
    <time_frame>9 months</time_frame>
    <description>Incidence of acute respiratory tract infection</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2099</enrollment>
  <condition>Respiratory Tract Infections</condition>
  <condition>Covid19</condition>
  <condition>Flu Like Illness</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D supplementation</intervention_name>
    <description>Daily vitamin D3 supplementation (5000 IU)</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hospital worker&#xD;
&#xD;
          -  Age 52 years or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of hypercalcemia&#xD;
&#xD;
          -  History of nephrolithiasis&#xD;
&#xD;
          -  History of intolerance to vitamin D3 supplements&#xD;
&#xD;
          -  Use of calcium at a dose &gt; 600 mg/day (individuals using a dose greater than 600 mg of&#xD;
             calcium per day will be asked to limit the amount to 600 mg unless they have been&#xD;
             directed by their physician to be taking more than 600 mg/day of calcium. If the&#xD;
             latter is true the potential subject will be excluded from the study.)&#xD;
&#xD;
          -  Use of vitamin D at a daily dose â‰¥ 5000 IU*&#xD;
&#xD;
          -  Use of aluminum-containing phosphate binders in patients with renal failure&#xD;
&#xD;
          -  Use of calcipotriene&#xD;
&#xD;
          -  Use of digoxin&#xD;
&#xD;
          -  Use of thiazide diuretics if using:&#xD;
&#xD;
               -  hydrochlorothiazide at a daily dose &gt; 37.5 mg&#xD;
&#xD;
               -  indapamide at a daily dose &gt; 1.25 mg&#xD;
&#xD;
               -  chlorthalidone at a daily dose &gt; 12.5 mg&#xD;
&#xD;
               -  metolazone at a daily dose &gt; 2.5 mg&#xD;
&#xD;
               -  methyclothiazide at a daily dose &gt; 2.5 mg&#xD;
&#xD;
               -  chlorothiazide at a daily dose &gt; 250 mg&#xD;
&#xD;
               -  metolazone at a daily dose &gt; 0.5 mg&#xD;
&#xD;
               -  bendroflumethiazide at a daily dose &gt; 2.5 mg&#xD;
&#xD;
               -  polythiazide at a daily dose &gt; 1 mg&#xD;
&#xD;
               -  hydroflumethiazide at a daily dose &gt; 25 mg&#xD;
&#xD;
          -  Conditions that are associated with a risk of modified vitamin D metabolism&#xD;
&#xD;
          -  Known allergy to wool&#xD;
&#xD;
          -  Current enrollment in another study&#xD;
&#xD;
          -  Life expectancy &lt;1 month at time of screening&#xD;
&#xD;
          -  Cognitive impairment precluding the ability to provide informed consent&#xD;
&#xD;
          -  Pregnant or trying to become pregnant&#xD;
&#xD;
               -  If potential participants are found to be using vitamin D supplementation upon&#xD;
                  screening at a daily dose lower than 5000 IU/day, they will be eligible for&#xD;
                  participation by switching to the higher study dose. If potential participants&#xD;
                  are taking a multiple vitamin and there is less than or equal to 800 IU vitamin D&#xD;
                  in it, they can continue the multivitamin along with taking the study vitamin D3.&#xD;
                  If potential participants are found to be using vitamin D supplementation at a&#xD;
                  daily dose greater than or equal to 5000 IU they will not be eligible to&#xD;
                  participate in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>52 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Noud van Helmond, MD</last_name>
    <phone>(800) 826-6737</phone>
    <email>vanhelmond-noud@cooperhealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noud van Helmond, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>November 19, 2020</last_update_submitted>
  <last_update_submitted_qc>November 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

